News Overview

KSS Limited had intimated the 25-Apr-2022 for the purpose of Confirmation pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November & . The Company now cancelled the said RecordDate

Asian Granito India Limited has informed the Exchange about press release dated 25-Apr-2022 titled Asian Granito India Ltds Rs.441 Crores Rights Issue opens for subscription.

Bhagyanagar Properties Limited has informed the Exchange about Board Meeting held on 25-Apr-2022 to consider Voluntary delisting

JHS : Significant movement in price has been observed in JHS Svendgaard Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. JHS Svendgaard Laboratories Limited has submitted their response.

Likely to post strong, all-round performance

In continuation to our letter dated April 19, 2022 and pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting scheduled on Thursday, April 28, 2022 shall inter-alia, also consider the proposal for declaration of Bonus Issue of Equity Shares (i.e. in addition to consider and approve the Unaudited Financial Results of the Company, both on Standalone and Consolidated basis, for the Quarter ended March 31, 2022).

PPAP Automotive Limited has informed the Exchange about appointment of Pankhuri Agarwal as Compliance Officer of the company w.e.f. 26-Apr-2022

JSW Steel Limited has informed the Exchange about press release dated 25-Apr-2022 titled Clarification on acquisition of Pawan Hans

Sansera Engineering Limited has informed the Exchange about press release dated 25-Apr-2022 titled Sansera Receives Multiple Industry Awards

Zydus Lifesciences Limited has informed the Exchange about press release dated 25-Apr-2022 titled Zydus announces publication of ???DREAM-ND??? and ???DREAM-D??? Phase 3 trials of Desidustat in ???American Journal of Nephrology???